Episode

Ep187: Eric Fischer on Creating a New Class of Medicines

Podcast

The Long Run with Luke Timmerman

Published

Oct 14, 2025

Duration seconds

3948

Processing state

not_requested

Canonical source

https://soundcloud.com/longrunpodcast/ep187-eric-fischer-on-creating-a-new-class-of-medicines

Audio

https://feeds.soundcloud.com/stream/2190109907-longrunpodcast-ep187-eric-fischer-on-creating-a-new-class-of-medicines.mp3

JSON

/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep187-eric-fischer-on-creating-a-new-class-of-medicines

Markdown

/podcast/the-long-run-with-luke-timmerman-1124799/ep187-eric-fischer-on-creating-a-new-class-of-medicines.md

Actions

• POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep187-eric-fischer-on-creating-a-new-class-of-medicines/transcription-requests
  Idempotently request low-priority transcript generation for this episode.
• GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep187-eric-fischer-on-creating-a-new-class-of-medicines.md
  Read the agent-friendly Markdown representation of this episode resource.

Summary

Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.